首页> 外文学位 >Ischemic and pharmacological preconditioning of rat myocardium: Effects on ischemia-reperfusion injury.
【24h】

Ischemic and pharmacological preconditioning of rat myocardium: Effects on ischemia-reperfusion injury.

机译:大鼠心肌缺血和药理预处理:对缺血再灌注损伤的影响。

获取原文
获取原文并翻译 | 示例

摘要

Ischemic heart disease remains the major cause of morbidity and mortality in industrialized countries despite the improvement in clinical management of the disease. The search for therapeutic agents aimed at the protection against ischemia-reperfusion (I-R) injury has been an area of intensive research. This thesis work examined and compared the effects of ischemic preconditioning (IPC), produced by brief periods of myocardial ischemia followed by reperfusion, and pharmacological preconditioning (PPC), using active extracts or compounds derived from Chinese tonifying herbs of different functionality, on I-R injury in isolated-perfused hearts prepared from male and female rats. Adult female rat hearts were found to be less susceptible to I-R injury than that of male hearts. Correlation analysis indicated that mitochondrial reduced glutathione (GSH) and alpha-tocopherol (alpha-TOC) levels as well as Se-glutathione peroxidase (GPX) activity are crucial factors involved in the development of myocardial I-R injury. IPC could alter myocardial mitochondrial antioxidant component levels/activities and protect against myocardial I-R injury in a gender-independent manner. PPC produced differential effects on mitochondrial functional ability and antioxidant components and protected against myocardial I-R injury. While the methanolic extract of Herba Cynomorii and the saponin fraction of a mixture of Radix Ginseng and Radix Ophiopogonis (SF) produced a more favorable effect on male hearts, oleanolic acid (OA) and emodin (EMD) seemed to be more effective in female hearts. Both alpha-TOC and alpha-lipoic acid pretreatments were found to be more beneficial in protecting against I-R injury in female than in male hearts. The gender difference in cardioprotection afforded by PPC might be attributed to the differential response in mitochondrial functional ability and antioxidant components in non-I-R and I-R conditions. Biochemical mechanisms involved in the cardioprotection afforded by OA/EMD include the enhancement of GSH or its related antioxidant actions such as GSH-dependent recycling of alpha-TOC and the induction of heat shock protein 25/70 expression. Results obtained from studies using a combination of preconditioning pretreatments indicated that IPC and PPC (afforded by OA/EMD pretreatment) protected against myocardial I-R injury via similar but not identical biochemical mechanism. In vitro studies on mitochondrial susceptibility to peroxide-induced oxidation of lipids and Ca2+/PO43--induced permeability transition indicated that the cardioprotective mechanism of IPC and PPC may involve the enhancement of mitochondrial antioxidant capacity and resistant to calcium loading. The use of a combination of preconditioning agents may provide a better cardioprotection against I-R injury.
机译:尽管改善了疾病的临床管理,但缺血性心脏病仍是工业化国家发病率和死亡率的主要原因。寻找针对缺血-再灌注(I-R)损伤的治疗剂的研究已成为深入研究的领域。本论文研究并比较了短暂心肌缺血再灌注引起的缺血预处理(IPC)和药理预处理(PPC)使用活性提取物或不同功能中药的化合物提取物对IR损伤的影响从雄性和雌性大鼠中制备的离体灌流心脏中提取。发现成年雌性大鼠心脏比雄性心脏更不易受I-R损伤。相关分析表明,线粒体降低的谷胱甘肽(GSH)和α-生育酚(α-TOC)水平以及硒谷胱甘肽过氧化物酶(GPX)活性是参与心肌I-R损伤发展的关键因素。 IPC可以以性别无关的方式改变心肌线粒体抗氧化剂成分的水平/活性,并防止心肌I-R损伤。 PPC对线粒体功能能力和抗氧化剂成分产生不同的影响,并保护其免受心肌I-R损伤。虽然人参的甲醇提取物以及人参和麦冬混合物(SF)的皂苷成分对男性心脏产生更好的影响,但齐墩果酸(OA)和大黄素(EMD)似乎对女性心脏更有效。发现在女性中比在男性心脏中,α-TOC和α-硫辛酸预处理在预防I-R损伤方面更有益。 PPC提供的心脏保护作用的性别差异可能归因于非I-R和I-R条件下线粒体功能能力和抗氧化剂成分的差异反应。 OA / EMD提供的参与心脏保护的生化机制包括增强GSH或其相关的抗氧化作用,例如GSH依赖的α-TOC循环利用和诱导热休克蛋白25/70的表达。使用预处理组合的研究获得的结果表明,IPC和PPC(通过OA / EMD预处理承担)通过相似但不完全相同的生化机制来保护心肌免受I-R损伤。线粒体对过氧化物诱导的脂质氧化和Ca2 + / PO43诱导的通透性转变的敏感性的体外研究表明,IPC和PPC的心脏保护机制可能涉及增强线粒体的抗氧化能力并抗钙负荷。组合使用预处理剂可以提供更好的抗I-R损伤的心脏保护作用。

著录项

  • 作者

    Du, Ying.;

  • 作者单位

    Hong Kong University of Science and Technology (People's Republic of China).;

  • 授予单位 Hong Kong University of Science and Technology (People's Republic of China).;
  • 学科 Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2005
  • 页码 253 p.
  • 总页数 253
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

  • 入库时间 2022-08-17 11:41:16

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号